Is TGF-beta a profibrotic cytokine in human renal transplants?
Nicholson
M L
ML
University Department of Surgery, Leicester General Hospital, UK.
Bicknell
G R
GR
Williams
S T
ST
Furness
P N
PN
D000328:Adult; D000368:Aged; D003094:Collagen / Q000096:biosynthesis; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D018093:Gelatinases / Q000096:biosynthesis; D005786:Gene Expression Regulation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008297:Male; D020778:Matrix Metalloproteinase 2; D008666:Metalloendopeptidases / Q000096:biosynthesis; D008875:Middle Aged; D012333:RNA, Messenger / Q000096:biosynthesis; D016559:Tacrolimus / Q000627:therapeutic use; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000096:biosynthesis; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000096:biosynthesis; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000096:biosynthesis*
D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D019715:Tissue Inhibitor of Metalloproteinase-1; D016212:Transforming Growth Factor beta; D019716:Tissue Inhibitor of Metalloproteinase-2; D016572:Cyclosporine; D003094:Collagen; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D016559:Tacrolimus